SGMO

Sangamo Therapeutics, Inc. Common Stock

$0.18 +31.56%

Recent alerts on SGMO

All signals →

News US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being'

News Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact

News Sangamo anticipates completing ST-920 BLA submission as early as this summer while appealing NASDAQ delisting in June

Short volume Short volume 61% of volume (5.7σ)

Short volume Short volume 52% of volume (4.1σ)

SEC filing SGMO Delisted Nasdaq After $1.00 Bid Price Breach, 30-Day Rule, 180-Day Extension Missed, Trading Suspended May 5, OTCQB Uplift Approved

Insider trade Sale by Nathalie Dubois-Stringfellow (SVP-CHIEF DEVELOPMENT OFFICER)

Insider trade Sale by Gregory D Davis (Head of Research & Technology)

Insider trade Sale by Nathalie Dubois-Stringfellow (SVP-CHIEF DEVELOPMENT OFFICER)

Insider trade Sale by Gregory D Davis (Head of Research & Technology)

Short volume Short volume 80% of volume (3.9σ)

News Sangamo plunges after pricing stock offering; principal financial officer exits

SEC filing Results of Operations and Financial Condition

News Sangamo Therapeutics (SGMO) Shares Stabilize Amid Recent Key Pipeline Update

Get push alerts for SGMO

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS